🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#ASCO25 - giving an exceptional distillation is really a skill. I have been blown away today by the distillations. Anwaar Saeed just gave a distillation on treatment of gastroesophageal cancers (Satri-cel vs TPC) that made this gynecologic oncologist feel moderately

#ASCO25 - congratulations to Erika Hamilton, MD and the VERITAC-2 team on this data. We have ESR1m endometrial cancer - is it time to move some of these active endocrine therapies to gyn? We are tired of letrozole and MPA.......

So incredibly well deserved

Woot!!!

#ASCO25 #NRG Cooperative group science at ASCO! Thx for posting David Scott Miller

#ASCO25 join us today at 1130 in S102 for a discussion about practice advancements in gynecologic cancer! Excited to be joined by Dr Joyce Liu and Ketta lorusso #uterinecancermonth #jumpforjune

#ASCO25 Gyn Cancer Orals Underway! First up: TRUST This was primary cytoreduction vs NACT and iCRS done by high volume, highly skilled surgeons. Primary endpoint of OS in ITT was NOT met. Large subgroup of stage III suggests benefit. Those with complete cytoreduction also

#ASCO25 #NRG Thanks David Scott Miller

Could not be more proud of Rafeh Naqash, MD and his lab at #ASCO25. They have represented OU Health Stephenson Cancer Center and the OU College of Medicine at the highest level. Excellent science, education and leadership across the board. BoomerSooner!

#ASCO25 OU Health Stephenson Cancer Center Debra Richardson, M.D. Emi-Le(B7H4 ADC) Proud to have this open and available to our patients in OKC

#ASCO25 ctDNA from the CALLA Study of cervical cancer take aways: 1) baseline detection of ctDNA for pts with local regionally advanced disease is 99% 2) Among pts on the durva arm, at cycle 3, 38% of pts had "+" ctDNA and by cycle 6 this dropped to 23%. (figure 1) 3) pts with

#ASCO25 ROSELLA exciting preliminary findings for relacorilant plus nab paclitaxel in PROC HR .70 for PFS OS is not mature but there is a signal of superiority. Will be looking forward to mature data to help prioritize this combo vs other taxane options!

#ASCO25 GSK FIRST presented today - I am proud of this trial as the US PI and the contribution of our sites and grace of our patients in participating. But- statistical significance did not translate to clinical relevance so we must say - no role for CPI in FL EOC.

#ASCO25 OU Health Stephenson Cancer Center Debra Richardson, M.D. SCC continues to shine at ASCO with Dr Debra Richardson distilling 3 leading oral abstracts in gyn cancer! Awesome job

It’s official! Dr. Eric Small assumes his role as @asco 2025-26 president and introduces his theme. #asco25 ASCOPres

Happening now at #ASCO25! Dr. Naqash serves as chair during the Oral Abstract Session: Lung Cancer-Non- Small Cell Local-Regional/ Small Cell/ Other Thoracic Cancers session.

#ASCO25 Thank you for asking me to chair a clinical science session on gynecologic cancers. It was my absolute honor to work with exceptional faculty and present to a packed room today. Thanks to Drs. Joyce Liu and Ketta Lorusso who brought comprehensive, forward thinking ideas

So delighted to be on this list of smart patient centered clinician scientists who are women! I think we all tried to celebrate the presented data in a measured tone. Lots of new data but so much still to learn.